Pfizer vaccine trial data raise students’ hopes for normalcy
With the news that Pfizer’s vaccine is 100 percent effective in 12- to 15-year-old children, and the vaccine already approved for ages 16 and up, a return to “normal” school may be on the horizon. Pfizer recently completed its clinical trial in the 12-15 age group and is hoping to get the vaccine approved for…